APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omics Analysis Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omics Analysis Software Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchOmics Analysis Software Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Omics Analysis Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Omics Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omics Analysis Software Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Omics Analysis Software Market Analysis and Forecast 2026-2032256 pages · $4,950 USD

Market perspective

The global Omics Analysis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omics Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omics Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omics Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omics Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omics Analysis Software market include AI Verse, Appen, Gretel, TagX, GTS, Labelbox, Pangeanic, Pixta AI and Sapien, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Omics Analysis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omics Analysis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omics Analysis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Omics Analysis Software market.

Omics Analysis Software Segment by Company

AI Verse

Appen

Gretel

TagX

GTS

Labelbox

Pangeanic

Pixta AI

Sapien

Scale AI

Shaip

SuperAnnotate

Soundsnap

Omics Analysis Software Segment by Type

Genomics Analysis Software

Transcriptomics Analysis Software

Proteomics Analysis Software

Metabolomics Analysis Software

Environmental Toxicology Analysis Software

Epigenomics Analysis Software

Others

Omics Analysis Software Segment by Application

Scientific Research

Clinical Diagnostics and Precision Medicine

Agriculture and Biotechnology

Drug Discovery

Others

Omics Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Omics Analysis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Omics Analysis Software key companies, revenue, market share, and recent developments.

3. To split the Omics Analysis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Omics Analysis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omics Analysis Software significant trends, drivers, influence factors in global and regions.

6. To analyze Omics Analysis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omics Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omics Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omics Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omics Analysis Software industry.

Chapter 3: Detailed analysis of Omics Analysis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Omics Analysis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Omics Analysis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omics Analysis Software Industry Trends Table 2. Omics Analysis Software Industry Drivers Table 3. Omics Analysis Software Industry Opportunities and Challenges Table 4. Omics Analysis Software Industry Restraints Table 5. Global Omics Analysis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omics Analysis Software Revenue Share by Company (2021-2026) Table 7. Global Omics Analysis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Omics Analysis Software Key Company Manufacturing Base & Headquarters Table 9. Global Omics Analysis Software Company, Product Type & Application Table 10. Global Omics Analysis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Omics Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Genomics Analysis Software Table 15. Significant Companies of Transcriptomics Analysis Software Table 16. Significant Companies of Proteomics Analysis Software Table 17. Significant Companies of Metabolomics Analysis Software Table 18. Significant Companies of Environmental Toxicology Analysis Software Table 19. Significant Companies of Epigenomics Analysis Software Table 20. Significant Companies of Others Table 21. Global Omics Analysis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Omics Analysis Software Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Omics Analysis Software Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Omics Analysis Software Sales Value Share by Type (2021-2026) Table 25. Global Omics Analysis Software Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Scientific Research Table 27. Significant Companies of Clinical Diagnostics and Precision Medicine Table 28. Significant Companies of Agriculture and Biotechnology Table 29. Significant Companies of Drug Discovery Table 30. Significant Companies of Others Table 31. Global Omics Analysis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Omics Analysis Software Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Omics Analysis Software Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Omics Analysis Software Sales Value Share by Application (2021-2026) Table 35. Global Omics Analysis Software Sales Value Share by Application (2027-2032) Table 36. Global Omics Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Omics Analysis Software Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Omics Analysis Software Sales Value Share by Region (2021-2026) Table 39. Global Omics Analysis Software Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Omics Analysis Software Sales Value Share by Region (2027-2032) Table 41. Global Omics Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Omics Analysis Software Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Omics Analysis Software Sales Value Market Share by Country (2021-2026) Table 44. Global Omics Analysis Software Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Omics Analysis Software Sales Value Market Share by Country (2027-2032) Table 46. AI Verse Company Information Table 47. AI Verse Business Overview Table 48. AI Verse Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. AI Verse Omics Analysis Software Product Portfolio Table 50. AI Verse Recent Development Table 51. Appen Company Information Table 52. Appen Business Overview Table 53. Appen Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Appen Omics Analysis Software Product Portfolio Table 55. Appen Recent Development Table 56. Gretel Company Information Table 57. Gretel Business Overview Table 58. Gretel Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Gretel Omics Analysis Software Product Portfolio Table 60. Gretel Recent Development Table 61. TagX Company Information Table 62. TagX Business Overview Table 63. TagX Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. TagX Omics Analysis Software Product Portfolio Table 65. TagX Recent Development Table 66. GTS Company Information Table 67. GTS Business Overview Table 68. GTS Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GTS Omics Analysis Software Product Portfolio Table 70. GTS Recent Development Table 71. Labelbox Company Information Table 72. Labelbox Business Overview Table 73. Labelbox Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Labelbox Omics Analysis Software Product Portfolio Table 75. Labelbox Recent Development Table 76. Pangeanic Company Information Table 77. Pangeanic Business Overview Table 78. Pangeanic Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Pangeanic Omics Analysis Software Product Portfolio Table 80. Pangeanic Recent Development Table 81. Pixta AI Company Information Table 82. Pixta AI Business Overview Table 83. Pixta AI Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Pixta AI Omics Analysis Software Product Portfolio Table 85. Pixta AI Recent Development Table 86. Sapien Company Information Table 87. Sapien Business Overview Table 88. Sapien Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Sapien Omics Analysis Software Product Portfolio Table 90. Sapien Recent Development Table 91. Scale AI Company Information Table 92. Scale AI Business Overview Table 93. Scale AI Omics Analysis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Scale AI Omics Analysis Software Product Portfolio Table 95. Scale AI Recent Development Table 96. Shaip Company Information Table 97. Shaip Business Overview Table 98. Shaip Omics Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Shaip Omics Analysis Software Product Portfolio Table 100. Shaip Recent Development Table 101. SuperAnnotate Company Information Table 102. SuperAnnotate Business Overview Table 103. SuperAnnotate Omics Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. SuperAnnotate Omics Analysis Software Product Portfolio Table 105. SuperAnnotate Recent Development Table 106. Soundsnap Company Information Table 107. Soundsnap Business Overview Table 108. Soundsnap Omics Analysis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Soundsnap Omics Analysis Software Product Portfolio Table 110. Soundsnap Recent Development Table 111. Research Programs/Design for This Report Table 112. Authors List of This Report Table 113. Secondary Sources Table 114. Primary Sources List of Figures Figure 1. Omics Analysis Software Product Image Figure 2. Global Omics Analysis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omics Analysis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Omics Analysis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Genomics Analysis Software Image Figure 8. Transcriptomics Analysis Software Image Figure 9. Proteomics Analysis Software Image Figure 10. Metabolomics Analysis Software Image Figure 11. Environmental Toxicology Analysis Software Image Figure 12. Epigenomics Analysis Software Image Figure 13. Others Image Figure 14. Global Omics Analysis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Omics Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Omics Analysis Software Sales Value Share by Type (2021-2032) Figure 17. Scientific Research Image Figure 18. Clinical Diagnostics and Precision Medicine Image Figure 19. Agriculture and Biotechnology Image Figure 20. Drug Discovery Image Figure 21. Others Image Figure 22. Global Omics Analysis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Omics Analysis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Omics Analysis Software Sales Value Share by Application (2021-2032) Figure 25. Global Omics Analysis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Omics Analysis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Omics Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 28. North America Omics Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Omics Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Omics Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Omics Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Omics Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Omics Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 34. South America Omics Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Omics Analysis Software Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Omics Analysis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Omics Analysis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Omics Analysis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Omics Analysis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Genomics Analysis Software
  • Transcriptomics Analysis Software
  • Proteomics Analysis Software
  • Metabolomics Analysis Software
  • Environmental Toxicology Analysis Software
  • Epigenomics Analysis Software
  • Others
Applications
  • Scientific Research
  • Clinical Diagnostics and Precision Medicine
  • Agriculture and Biotechnology
  • Drug Discovery
  • Others
Companies covered
  • AI Verse
  • Appen
  • Gretel
  • TagX
  • GTS
  • Labelbox
  • Pangeanic
  • Pixta AI
  • Sapien
  • Scale AI
  • Shaip
  • SuperAnnotate
  • Soundsnap

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Omics Analysis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Omics Analysis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Omics Analysis Software Market Dynamics
  1. 2.1 Omics Analysis Software Industry Trends
  2. 2.2 Omics Analysis Software Industry Drivers
  3. 2.3 Omics Analysis Software Industry Opportunities and Challenges
  4. 2.4 Omics Analysis Software Industry Restraints
3 Omics Analysis Software Market by Company
  1. 3.1 Global Omics Analysis Software Company Revenue Ranking in 2025
  2. 3.2 Global Omics Analysis Software Revenue by Company (2021-2026)
  3. 3.3 Global Omics Analysis Software Company Ranking (2024-2026)
  4. 3.4 Global Omics Analysis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Omics Analysis Software Company Product Type and Application
  6. 3.6 Global Omics Analysis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Omics Analysis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Omics Analysis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Omics Analysis Software Market by Type
  1. 4.1 Omics Analysis Software Type Introduction
  2. 4.1.1 Genomics Analysis Software
  3. 4.1.2 Transcriptomics Analysis Software
  4. 4.1.3 Proteomics Analysis Software
  5. 4.1.4 Metabolomics Analysis Software
  6. 4.1.5 Environmental Toxicology Analysis Software
  7. 4.1.6 Epigenomics Analysis Software
  8. 4.1.7 Others
  9. 4.2 Global Omics Analysis Software Sales Value by Type
  10. 4.2.1 Global Omics Analysis Software Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Omics Analysis Software Sales Value by Type (2021-2032)
  12. 4.2.3 Global Omics Analysis Software Sales Value Share by Type (2021-2032)
5 Omics Analysis Software Market by Application
  1. 5.1 Omics Analysis Software Application Introduction
  2. 5.1.1 Scientific Research
  3. 5.1.2 Clinical Diagnostics and Precision Medicine
  4. 5.1.3 Agriculture and Biotechnology
  5. 5.1.4 Drug Discovery
  6. 5.1.5 Others
  7. 5.2 Global Omics Analysis Software Sales Value by Application
  8. 5.2.1 Global Omics Analysis Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Omics Analysis Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global Omics Analysis Software Sales Value Share by Application (2021-2032)
6 Omics Analysis Software Regional Value Analysis
  1. 6.1 Global Omics Analysis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omics Analysis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Omics Analysis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Omics Analysis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Omics Analysis Software Sales Value (2021-2032)
  7. 6.3.2 North America Omics Analysis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Omics Analysis Software Sales Value (2021-2032)
  10. 6.4.2 Europe Omics Analysis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Omics Analysis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Omics Analysis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Omics Analysis Software Sales Value (2021-2032)
  16. 6.6.2 South America Omics Analysis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Omics Analysis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Omics Analysis Software Sales Value Share by Country, 2025 VS 2032
7 Omics Analysis Software Country-level Value Analysis
  1. 7.1 Global Omics Analysis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omics Analysis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Omics Analysis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Omics Analysis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Omics Analysis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Omics Analysis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Omics Analysis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Omics Analysis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Omics Analysis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Omics Analysis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Omics Analysis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Omics Analysis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Omics Analysis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Omics Analysis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Omics Analysis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Omics Analysis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Omics Analysis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Omics Analysis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Omics Analysis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Omics Analysis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Omics Analysis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Omics Analysis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Omics Analysis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Omics Analysis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Omics Analysis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Omics Analysis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Omics Analysis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Omics Analysis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Omics Analysis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Omics Analysis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Omics Analysis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Omics Analysis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Omics Analysis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Omics Analysis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AI Verse
  2. 8.1.1 AI Verse Company Information
  3. 8.1.2 AI Verse Business Overview
  4. 8.1.3 AI Verse Omics Analysis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AI Verse Omics Analysis Software Product Portfolio
  6. 8.1.5 AI Verse Recent Developments
  7. 8.2 Appen
  8. 8.2.1 Appen Company Information
  9. 8.2.2 Appen Business Overview
  10. 8.2.3 Appen Omics Analysis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Appen Omics Analysis Software Product Portfolio
  12. 8.2.5 Appen Recent Developments
  13. 8.3 Gretel
  14. 8.3.1 Gretel Company Information
  15. 8.3.2 Gretel Business Overview
  16. 8.3.3 Gretel Omics Analysis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gretel Omics Analysis Software Product Portfolio
  18. 8.3.5 Gretel Recent Developments
  19. 8.4 TagX
  20. 8.4.1 TagX Company Information
  21. 8.4.2 TagX Business Overview
  22. 8.4.3 TagX Omics Analysis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TagX Omics Analysis Software Product Portfolio
  24. 8.4.5 TagX Recent Developments
  25. 8.5 GTS
  26. 8.5.1 GTS Company Information
  27. 8.5.2 GTS Business Overview
  28. 8.5.3 GTS Omics Analysis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GTS Omics Analysis Software Product Portfolio
  30. 8.5.5 GTS Recent Developments
  31. 8.6 Labelbox
  32. 8.6.1 Labelbox Company Information
  33. 8.6.2 Labelbox Business Overview
  34. 8.6.3 Labelbox Omics Analysis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Labelbox Omics Analysis Software Product Portfolio
  36. 8.6.5 Labelbox Recent Developments
  37. 8.7 Pangeanic
  38. 8.7.1 Pangeanic Company Information
  39. 8.7.2 Pangeanic Business Overview
  40. 8.7.3 Pangeanic Omics Analysis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pangeanic Omics Analysis Software Product Portfolio
  42. 8.7.5 Pangeanic Recent Developments
  43. 8.8 Pixta AI
  44. 8.8.1 Pixta AI Company Information
  45. 8.8.2 Pixta AI Business Overview
  46. 8.8.3 Pixta AI Omics Analysis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pixta AI Omics Analysis Software Product Portfolio
  48. 8.8.5 Pixta AI Recent Developments
  49. 8.9 Sapien
  50. 8.9.1 Sapien Company Information
  51. 8.9.2 Sapien Business Overview
  52. 8.9.3 Sapien Omics Analysis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sapien Omics Analysis Software Product Portfolio
  54. 8.9.5 Sapien Recent Developments
  55. 8.10 Scale AI
  56. 8.10.1 Scale AI Company Information
  57. 8.10.2 Scale AI Business Overview
  58. 8.10.3 Scale AI Omics Analysis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Scale AI Omics Analysis Software Product Portfolio
  60. 8.10.5 Scale AI Recent Developments
  61. 8.11 Shaip
  62. 8.11.1 Shaip Company Information
  63. 8.11.2 Shaip Business Overview
  64. 8.11.3 Shaip Omics Analysis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shaip Omics Analysis Software Product Portfolio
  66. 8.11.5 Shaip Recent Developments
  67. 8.12 SuperAnnotate
  68. 8.12.1 SuperAnnotate Company Information
  69. 8.12.2 SuperAnnotate Business Overview
  70. 8.12.3 SuperAnnotate Omics Analysis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 SuperAnnotate Omics Analysis Software Product Portfolio
  72. 8.12.5 SuperAnnotate Recent Developments
  73. 8.13 Soundsnap
  74. 8.13.1 Soundsnap Company Information
  75. 8.13.2 Soundsnap Business Overview
  76. 8.13.3 Soundsnap Omics Analysis Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Soundsnap Omics Analysis Software Product Portfolio
  78. 8.13.5 Soundsnap Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst